← Back to headlines
Barclays Lowers Price Target on Hims & Hers Health (HIMS)
Barclays has lowered its price target on Hims & Hers Health, Inc. (HIMS) to $25 while keeping an Overweight rating.
5 Mar, 20:28 — 5 Mar, 20:28
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Philippine President's Aid Distribution in Batangas Sparks Controversy
just now
Bus Fire Disrupts MRT-3 Operations in Manila
just now
Witness Alleges P1.5 Billion Project Allocation and P500 Million Cash for Former Senator Revilla
just now